Literature DB >> 16688226

Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia.

F Weerkamp1, J J M van Dongen, F J T Staal.   

Abstract

Many acute lymphoblastic leukemias can be considered as malignant counterparts of cells in the various stages of normal lymphoid development in bone marrow and thymus. T-cell development in the thymus is an ordered and tightly controlled process. Two evolutionary conserved signaling pathways, which were first discovered in Drosophila, control the earliest steps of T-cell development. These are the Notch and Wnt-signaling routes, which both are deregulated in several types of leukemias. In this review we discuss both pathways, with respect to their signaling mechanisms, functions during T-cell development and their roles in development of leukemias, especially T-cell acute lymphoblastic leukemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16688226     DOI: 10.1038/sj.leu.2404255

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  28 in total

1.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 2.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 3.  Effects of Toll-like receptor signals in T-cell neoplasms.

Authors:  Cori Morrison; Maria R Baer; Dan P Zandberg; Amy Kimball; Eduardo Davila
Journal:  Future Oncol       Date:  2011-02       Impact factor: 3.404

4.  Arsenic trioxide increases expression of secreted frizzled-related protein 1 gene and inhibits the WNT/β-catenin signaling pathway in Jurkat cells.

Authors:  Yan Wang; Zunsong Wang; Hong Li; Wenwei Xu; Lin Dong; Yan Guo; Saran Feng; Kehong Bi; Chuansheng Zhu
Journal:  Exp Ther Med       Date:  2017-03-06       Impact factor: 2.447

5.  Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  Amanda L Cleaver; Alex H Beesley; Martin J Firth; Nina C Sturges; Rebecca A O'Leary; Stephen P Hunger; David L Baker; Ursula R Kees
Journal:  Mol Cancer       Date:  2010-05-12       Impact factor: 27.401

6.  Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.

Authors:  Ryan Morrison; Stephen M Schleicher; Yunguang Sun; Kenneth J Niermann; Sungjune Kim; Daniel E Spratt; Christine H Chung; Bo Lu
Journal:  J Oncol       Date:  2010-10-12       Impact factor: 4.375

Review 7.  Role of Wnt canonical pathway in hematological malignancies.

Authors:  Xueling Ge; Xin Wang
Journal:  J Hematol Oncol       Date:  2010-09-15       Impact factor: 17.388

8.  Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.

Authors:  Francesca Chiarini; Federica Falà; Pier Luigi Tazzari; Francesca Ricci; Annalisa Astolfi; Andrea Pession; Pasqualepaolo Pagliaro; James A McCubrey; Alberto M Martelli
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.

Authors:  Mai Xu; Qing Yu; Ramesh Subrahmanyam; Michael J Difilippantonio; Thomas Ried; Jyoti Misra Sen
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

Review 10.  The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis.

Authors:  Frank J T Staal; Jyoti M Sen
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.